Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|7|4|425-433

ISSN： 1570-162X

Source： Current HIV Research, Vol.7, Iss.4, 2009-07, pp. : 425-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Susceptibility of HIV-1 to Tipranavir and Other Antiretroviral Agents in Treatment-Experienced Patients: The UTILIZE Study

By  

Current HIV Research, Vol. 8, Iss. 4, 2010-06 ,pp. : 347-354

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of Protease Inhibitor (PI) Resistance-Associated Mutations Between PI-Naive and PI-Experienced HIV-1 Infected Patients in Thailand Where Subtype A/E is Predominant

By  

Current HIV Research, Vol. 8, Iss. 6, 2010-01 ,pp. : 456-460

Bentham Science Publishers

Access to resources Recommend Favorite

Reversal of Major Genotypic Tipranavir Mutations Under Long-Term Treatment with Tipranavir/Ritonavir Itself with Very Limited Optimized Background, During Deep Salvage Antiretroviral Therapy

By  

Current HIV Research, Vol. 7, Iss. 3, 2009-05 ,pp. : 311-313

Bentham Science Publishers

Access to resources Recommend Favorite

Phase 1 Single Dose Studies to Optimize the Pharmacokinetics of DG17, a Novel HIV-Protease Inhibitor Pro-Drug, Using Sodium Bicarbonate and Ritonavir

By  

Current HIV Research, Vol. 6, Iss. 3, 2008-05 ,pp. : 272-275

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

By Reigadas S.   Marcelin A. G.   Houssaïni A.   Yerly S.   Descamps D.   Plantier J. C.   Ruffault A.   Amiel C.   Trabaud M. A.   Flandre Philippe   Fleury H.   Masquelier B.   Roussel C.   Alloui C.   Leguillou-Guillemette H.   Bettinger D.   Pallier C.   Brun-Vezinet F.   Peytavin G.   Pinson P.   Vallet S.   Poveda J. D.   Mirand A.   Krivine A.   Auvray C.   de Rougemont A.   Signori-Schmuck A.   Bocket L.   Rogez S.   Tamalet C.   Schneider V.   Bouvier-Alias M.   Montes B.   Schvoerer E.   Ferré V.   Chaix M. L.   Guinard J.   Haim-Boukobza S.   Soulié C.   Flandre P.   Assoumou L.   Calvez V.   Maillard A.   Morand-Joubert L.   Chaplain C.   Delaugerre C.   Bourlet T.   Bertsch S.   Raymond S.   Marque-Juillet S.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 4, 2013-04 ,pp. : 969-972

Oxford University Press

Access to resources Recommend Favorite